Showing 19,261 - 19,280 results of 109,544 for search '(( 10 ((we decrease) OR (nn decrease)) ) OR ( 50 ((a decrease) OR (mean decrease)) ))', query time: 1.23s Refine Results
  1. 19261

    Fluorogenic Dimers as Bright Switchable Probes for Enhanced Super-Resolution Imaging of Cell Membranes by Ilya O. Aparin (4435837)

    Published 2022
    “…Here, to address these two fundamental problems, we propose a concept of ON/OFF switchable probes for SMLM (points accumulation for imaging in nanoscale topography, PAINT) based on fluorogenic dimers of bright cyanine dyes. …”
  2. 19262

    Fluorogenic Dimers as Bright Switchable Probes for Enhanced Super-Resolution Imaging of Cell Membranes by Ilya O. Aparin (4435837)

    Published 2022
    “…Here, to address these two fundamental problems, we propose a concept of ON/OFF switchable probes for SMLM (points accumulation for imaging in nanoscale topography, PAINT) based on fluorogenic dimers of bright cyanine dyes. …”
  3. 19263

    Fluorogenic Dimers as Bright Switchable Probes for Enhanced Super-Resolution Imaging of Cell Membranes by Ilya O. Aparin (4435837)

    Published 2022
    “…Here, to address these two fundamental problems, we propose a concept of ON/OFF switchable probes for SMLM (points accumulation for imaging in nanoscale topography, PAINT) based on fluorogenic dimers of bright cyanine dyes. …”
  4. 19264
  5. 19265

    Table 1_The impact of comorbidities on surgical outcome and mortality in minimally invasive mitral valve surgery: a systematic review.docx by Vanessa I. T. Zwaans (22163257)

    Published 2025
    “…Left atrial (LA) diameter decreased significantly from 50.37 mm preoperatively to 40.41%mm postoperatively (p < 0.001), LVDD was significantly reduced after MIMVS (p < 0.001). …”
  6. 19266

    Brincidofovir is a robust replication inhibitor against African swine fever virus <i>in vivo</i> and <i>in vitro</i> by Shibang Guo (16022925)

    Published 2023
    “…Brincidofovir reduces ASFV replication in a dose-dependent manner (IC<sub>50</sub> = 2.76 nM) without cytotoxicity (CC<sub>50</sub> = 58 μM). …”
  7. 19267

    Serum Metabolic Signatures Induced By a Three-Day Intensified Exercise Period Persist After 14 h of Recovery in Runners by David C. Nieman (322662)

    Published 2013
    “…Immediately following the 3-day exercise period, significant 2-fold or higher increases in 75 metabolites were measured, with all but 22 of these metabolites related to lipid/carnitine metabolism, 13 to amino acid/peptide metabolism, 4 to hemoglobin/porphyrin metabolism, and 3 to Krebs cycle intermediates (<i>q</i>-values < 0.001). After a 14 h overnight recovery period, 50 of the 75 metabolites remained elevated, with 8 decreased (primarily amino acid-related metabolites) (<i>q</i>-values < 0.05). …”
  8. 19268
  9. 19269
  10. 19270

    Data Sheet 1_Efficacy and safety of hydroxyurea therapy on patients with β-thalassemia: a systematic review and meta-analysis.pdf by Tianmin Huang (20561477)

    Published 2025
    “…HU, in transfusion-dependent β-thalassemia patients, was related to a significant decrease in transfusion requirements [a pooled RR of 0.37 and a pooled good RR of 0.65 (95% CI, 0.53–0.76)]; in transfusion-independent β-thalassemia patients, it was correlated to an excellent raise in Hb levels [a pooled RR of 0.20 (95% CI, 0.08–0.35) and a pooled good RR of 0.53 (95% CI, 0.41–0.65)]. …”
  11. 19271

    Data Sheet 3_Efficacy and safety of hydroxyurea therapy on patients with β-thalassemia: a systematic review and meta-analysis.pdf by Tianmin Huang (20561477)

    Published 2025
    “…HU, in transfusion-dependent β-thalassemia patients, was related to a significant decrease in transfusion requirements [a pooled RR of 0.37 and a pooled good RR of 0.65 (95% CI, 0.53–0.76)]; in transfusion-independent β-thalassemia patients, it was correlated to an excellent raise in Hb levels [a pooled RR of 0.20 (95% CI, 0.08–0.35) and a pooled good RR of 0.53 (95% CI, 0.41–0.65)]. …”
  12. 19272

    Data Sheet 2_Efficacy and safety of hydroxyurea therapy on patients with β-thalassemia: a systematic review and meta-analysis.pdf by Tianmin Huang (20561477)

    Published 2025
    “…HU, in transfusion-dependent β-thalassemia patients, was related to a significant decrease in transfusion requirements [a pooled RR of 0.37 and a pooled good RR of 0.65 (95% CI, 0.53–0.76)]; in transfusion-independent β-thalassemia patients, it was correlated to an excellent raise in Hb levels [a pooled RR of 0.20 (95% CI, 0.08–0.35) and a pooled good RR of 0.53 (95% CI, 0.41–0.65)]. …”
  13. 19273

    Image_1_Long-Term Increase in Cholesterol Is Associated With Better Cognitive Function: Evidence From a Longitudinal Study.TIF by Huamin Liu (6852678)

    Published 2021
    “…</p><p>Methods: A total of 4,915 participants aged ≥45 years with normal cognition in baseline were included. …”
  14. 19274
  15. 19275
  16. 19276
  17. 19277

    Table 1_Bioelectrical impedance vector analysis in older adults: reference standards from a cross-sectional study.docx by Francesco Campa (20997323)

    Published 2025
    “…Bioimpedance analysis was conducted using a phase-sensitive foot-to-hand technology at 50 kHz. …”
  18. 19278

    Table 2_Bioelectrical impedance vector analysis in older adults: reference standards from a cross-sectional study.docx by Francesco Campa (20997323)

    Published 2025
    “…Bioimpedance analysis was conducted using a phase-sensitive foot-to-hand technology at 50 kHz. …”
  19. 19279

    Data Sheet 1_The effect of Traditional Chinese Medicine on patients undergoing targeted therapy for primary liver cancer: a systematic review and meta-analysis.docx by Hongting Yan (13242201)

    Published 2025
    “…</p>Results<p>Targeted therapy for liver cancer patients who received TCM treatment showed improvements in objective response rate (ORR) (RR, 1.49 [1.33-1.66], P < 0.0001), disease control rate (DCR) (RR, 1.32 [1.25,1.40], P < 0.0001), the 1-year survival (RR, 1.50 [1.20,1.88]; P = 0.0004) and Karnofsky Performance Status (KPS) (SMD, 1.34 [0.86,1.81]; P < 0.0001), and can reduce the incidence of adverse events, as well as to some extent decrease the production of tumor markers and related inflammatory factors.…”
  20. 19280